New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilis
- 1 May 1995
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (5), 1199-1200
- https://doi.org/10.1128/aac.39.5.1199
Abstract
A clinical isolate of Proteus mirabilis was found to produce a new variant of the TEM-10 beta-lactamase gene. This is the first report of TEM-10 production by P. mirabilis and the first report of extended-spectrum beta-lactamase production by an isolate of this species recovered in the United States.Keywords
This publication has 15 references indexed in Scilit:
- Extended-spectrum β-lactamase in Proteus mirabilisJournal of Antimicrobial Chemotherapy, 1994
- Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 beta-lactamase genesAntimicrobial Agents and Chemotherapy, 1992
- More extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1991
- A standard numbering scheme for the class A β-lactamasesBiochemical Journal, 1991
- High-level resistance to cefotaxime and ceftazidime in Klebsiella pneumoniae isolates from Cleveland, OhioAntimicrobial Agents and Chemotherapy, 1991
- In vitro and in vivo Transferrable β‐Lactam Resistance Due to a New Plasmid‐Mediated Oxyiminocephalosporinase from a Clinical Isolate of Proteus mirabilisMicrobiology and Immunology, 1991
- Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1989
- Extended Broad-Spectrum -Lactamases Conferring Transferable Resistance to Newer -Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility PatternsClinical Infectious Diseases, 1988
- Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.Proceedings of the National Academy of Sciences, 1978
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977